secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2026-07-10T12:06:31+00:00
Accession:  0001104659-26-082433
Event type: dividend
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE declares special cash dividend of $0.38/share in connection with Yarrow merger
--------------------------------------------------------------------------------

- Estimated aggregate $16.5M special cash dividend ($0.38/share) declared; record date July 22, 2026.
- Dividend conditioned on closing of merger with Yarrow Bioscience; expected close on/about July 24, 2026.
- Stockholder vote on merger scheduled for July 16, 2026; dividend payable after close.
- Per-share amount based on 42,989,506 shares and equivalents outstanding as of July 9, 2026.
- Actual distribution may be higher or lower than estimate; payment to transfer agent on July 23, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/0001104659-26-082433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465926082433/tm2620182d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-082433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer